Marshall Kadin, MD
Professor
Boston University School of Medicine
Dept of Dermatology

MD, Northwestern University



Roger Williams Medical Center


Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

  1. Kadin ME, Morgan J, Xu H, Epstein AL, Sieber D, Hubbard BA, Adams WP, Bacchi CE, Goes JCS, Clemens MW, Medeiros LJ, Miranda RN. IL-13 is produced by tumor cells in Breast Implant Associated Anaplastic Large Cell Lymphoma: implications for pathogenesis. Hum Pathol. 2018 Apr 22. PMID: 29689246.
     
  2. Sun J, Yi S, Qiu L, Fu W, Wang A, Liu F, Wang L, Wang T, Chen H, Wang L, Kadin ME, Tu P, Wang Y. SATB1 Defines a Subtype of Cutaneous CD30+ Lymphoproliferative Disorders Associated with a T-Helper 17 Cytokine Profile. J Invest Dermatol. 2018 Mar 03. PMID: 29510190.
     
  3. Yi S, Sun J, Qiu L, Fu W, Wang A, Liu X, Yang Y, Kadin ME, Tu P, Wang Y. Dual Role of EZH2 in Cutaneous Anaplastic Large Cell Lymphoma: Promoting Tumor Cell Survival and Regulating Tumor Microenvironment. J Invest Dermatol. 2018 May; 138(5):1126-1136. PMID: 29248547.
     
  4. Kadin ME, Glicksman CA. Commentary on: Breast Implant-Associated Anaplastic Large-Cell Lymphoma in a Transgender Woman. Aesthet Surg J. 2017 Sep 01; 37(8):NP88-NP89. PMID: 29036946.
     
  5. Kadin ME, Morgan J, Xu H, Glicksman CA. CD30+ T Cells in Late Seroma May Not Be Diagnostic of Breast Implant-Associated Anaplastic Large Cell Lymphoma. Aesthet Surg J. 2017 07 01; 37(7):771-775. PMID: 28402493; DOI: 10.1093/asj/sjw286;.
     
  6. Perera LP, Zhang M, Nakagawa M, Petrus MN, Maeda M, Kadin ME, Waldmann TA, Perera PY. Chimeric antigen receptor modified T cells that target chemokine receptor CCR4 as a therapeutic modality for T-cell malignancies. Am J Hematol. 2017 Sep; 92(9):892-901. PMID: 28543380.
     
  7. Wang X, Dasari S, Nowakowski GS, Lazaridis KN, Wieben ED, Kadin ME, Feldman AL, Boddicker RL. Retinoic acid receptor alpha drives cell cycle progression and is associated with increased sensitivity to retinoids in T-cell lymphoma. Oncotarget. 2017 Apr 18; 8(16):26245-26255. PMID: 28412739; DOI: 10.18632/oncotarget.15441;.
     
  8. Chen J, Zhang Y, Petrus MN, Xiao W, Nicolae A, Raffeld M, Pittaluga S, Bamford RN, Nakagawa M, Ouyang ST, Epstein AL, Kadin ME, Del Mistro A, Woessner R, Jaffe ES, Waldmann TA. Cytokine receptor signaling is required for the survival of ALK- anaplastic large cell lymphoma, even in the presence of JAK1/STAT3 mutations. Proc Natl Acad Sci U S A. 2017 04 11; 114(15):3975-3980. PMID: 28356514; DOI: 10.1073/pnas.1700682114;.
     
  9. Fan P, Nong L, Sun J, Liu X, Kadin ME, Li T, Tu P, Wang Y. Primary cutaneous anaplastic large cell lymphoma with intralymphatic involvement associated with chronic lymphedema. J Cutan Pathol. 2017 Mar 23. PMID: 28337783; DOI: 10.1111/cup.12933;.
     
  10. Maliniemi P, Laukkanen K, Väkevä L, Dettmer K, Lipsanen T, Jeskanen L, Bessede A, Oefner PJ, Kadin ME, Ranki A. Biological and clinical significance of tryptophan-catabolizing enzymes in cutaneous T-cell lymphomas. Oncoimmunology. 2017; 6(3):e1273310. PMID: 28405495; DOI: 10.1080/2162402X.2016.1273310;.
     
Showing 10 of 270 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 258 publications over 39 distinct years, with a maximum of 15 publications in 1996

YearPublications
19802
19813
19823
19833
19843
19858
19865
19879
19888
19896
19908
19917
19926
19937
19949
19959
199615
199710
199814
19999
200012
20019
200210
200312
20046
20054
20063
20075
20084
20093
20106
20114
20122
20134
20149
20154
20166
20179
20182
Contact for Mentoring:


25 Buick St
Boston MA 02215
Google Map


Kadin's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Co-Authors
_
Similar People
_
Same Department